132 related articles for article (PubMed ID: 16365606)
1. Profiling providers on use of adjuvant chemotherapy by combining cancer registry and medical record data.
Zheng H; Yucel R; Ayanian JZ; Zaslavsky AM
Med Care; 2006 Jan; 44(1):1-7. PubMed ID: 16365606
[TBL] [Abstract][Full Text] [Related]
2. Combining information from cancer registry and medical records data to improve analyses of adjuvant cancer therapies.
He Y; Zaslavsky AM
Biometrics; 2009 Sep; 65(3):946-52. PubMed ID: 19210743
[TBL] [Abstract][Full Text] [Related]
3. Completeness of information on adjuvant therapies for colorectal cancer in population-based cancer registries.
Cress RD; Zaslavsky AM; West DW; Wolf RE; Felter MC; Ayanian JZ
Med Care; 2003 Sep; 41(9):1006-12. PubMed ID: 12972840
[TBL] [Abstract][Full Text] [Related]
4. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort.
Ayanian JZ; Zaslavsky AM; Fuchs CS; Guadagnoli E; Creech CM; Cress RD; O'Connor LC; West DW; Allen ME; Wolf RE; Wright WE
J Clin Oncol; 2003 Apr; 21(7):1293-300. PubMed ID: 12663717
[TBL] [Abstract][Full Text] [Related]
5. Validity of cancer registry data for measuring the quality of breast cancer care.
Malin JL; Kahn KL; Adams J; Kwan L; Laouri M; Ganz PA
J Natl Cancer Inst; 2002 Jun; 94(11):835-44. PubMed ID: 12048271
[TBL] [Abstract][Full Text] [Related]
6. Treatment and referral patterns for colorectal cancer.
Oliveria SA; Yood MU; Campbell UB; Yood SM; Stang P
Med Care; 2004 Sep; 42(9):901-6. PubMed ID: 15319616
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of interhospital variation in adjuvant chemotherapy for patients with Stage II/III colorectal cancer: a nationwide study.
Arakawa K; Kawai K; Tanaka T; Hata K; Sugihara K; Nozawa H
Colorectal Dis; 2018 Jul; 20(7):O162-O172. PubMed ID: 29752849
[TBL] [Abstract][Full Text] [Related]
8. A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer.
Lindskog EB; Gunnarsdóttir KÁ; Derwinger K; Wettergren Y; Glimelius B; Kodeda K
BMC Cancer; 2014 Dec; 14():948. PubMed ID: 25495897
[TBL] [Abstract][Full Text] [Related]
9. Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused.
Becerra AZ; Probst CP; Tejani MA; Aquina CT; González MG; Hensley BJ; Noyes K; Monson JR; Fleming FJ
Surgery; 2015 Sep; 158(3):692-9. PubMed ID: 26032822
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Guideline Adherence in Colorectal Cancer Treatment in The Netherlands: A Survey Among Medical Oncologists by the Dutch Colorectal Cancer Group.
Keikes L; van Oijen MGH; Lemmens VEPP; Koopman M; Punt CJA
Clin Colorectal Cancer; 2018 Mar; 17(1):58-64. PubMed ID: 29157662
[TBL] [Abstract][Full Text] [Related]
11. Variability in the quality of rectal cancer care in public hospitals in Catalonia (Spain): clinical audit as a basis for action.
Manchon-Walsh P; Borras JM; Espinas JA; Aliste L;
Eur J Surg Oncol; 2011 Apr; 37(4):325-33. PubMed ID: 21296543
[TBL] [Abstract][Full Text] [Related]
12. Stage III colon cancers: why adjuvant chemotherapy is not offered to elderly patients.
Mahoney T; Kuo YH; Topilow A; Davis JM
Arch Surg; 2000 Feb; 135(2):182-5. PubMed ID: 10668878
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Peer Support on Colorectal Cancer Patients' Adherence to Guideline-Concordant Multidisciplinary Care.
Kanters AE; Morris AM; Abrahamse PH; Mody L; Suwanabol PA
Dis Colon Rectum; 2018 Jul; 61(7):817-823. PubMed ID: 29771795
[TBL] [Abstract][Full Text] [Related]
14. Patterns of care for European colorectal cancer patients diagnosed 1996-1998: a EUROCARE high resolution study.
Gatta G; Zigon G; Aareleid T; Ardanaz E; Bielska-Lasota M; Galceran J; Góźdź S; Hakulinen T; Martinez-Garcia C; Plesko I; Zakelj MP; Rachtan J; Tagliabue G; Vercelli M; Faivre J
Acta Oncol; 2010 Aug; 49(6):776-83. PubMed ID: 20429733
[TBL] [Abstract][Full Text] [Related]
15. Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California.
Long B; Chang J; Ziogas A; Tewari KS; Anton-Culver H; Bristow RE
Am J Obstet Gynecol; 2015 Apr; 212(4):468.e1-9. PubMed ID: 25448522
[TBL] [Abstract][Full Text] [Related]
16. Patterns of chemotherapy use for women with ovarian cancer: a population-based study.
Cress RD; O'Malley CD; Leiserowitz GS; Campleman SL
J Clin Oncol; 2003 Apr; 21(8):1530-5. PubMed ID: 12697877
[TBL] [Abstract][Full Text] [Related]
17. Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011.
Zhao H; Zhang N; Ho V; Ding M; He W; Niu J; Yang M; Du XL; Zorzi D; Chavez-MacGregor M; Giordano SH
Cancer; 2018 Feb; 124(4):679-687. PubMed ID: 29140558
[TBL] [Abstract][Full Text] [Related]
18. Use of guideline-recommended adjuvant therapies and survival outcomes for people with colorectal cancer at tertiary referral hospitals in South Australia.
Adelson P; Fusco K; Karapetis C; Wattchow D; Joshi R; Price T; Sharplin G; Roder D
J Eval Clin Pract; 2018 Feb; 24(1):135-144. PubMed ID: 28474459
[TBL] [Abstract][Full Text] [Related]
19. Agreement of Iranian breast cancer data and relationships with measuring quality of care in a 5-year period (2006-2011).
Keshtkaran A; Sharifian R; Barzegari S; Talei A; Liu S; Tahmasebi H
Asian Pac J Cancer Prev; 2013; 14(3):2107-11. PubMed ID: 23679327
[TBL] [Abstract][Full Text] [Related]
20. Quality indicators for colorectal cancer surgery and care according to patient-, tumor-, and hospital-related factors.
Mathoulin-Pélissier S; Bécouarn Y; Belleannée G; Pinon E; Jaffré A; Coureau G; Auby D; Renaud-Salis JL; Rullier E;
BMC Cancer; 2012 Jul; 12():297. PubMed ID: 22813349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
